Overview
The study is a Comparative Clinical and Biochemical Study Evaluating the effect of Proton Pump I nhibitors versus histamine 2 Receptor antagonists as an adjuvant with chemotherapy in patients with Non-hodgkin Lymphoma.
Description
The study is a Comparative Clinical and Biochemical Study Evaluating the effect of Proton Pump Inhibitors versus histamine 2 Receptor antagonists as an adjuvant with chemotherapy in patients with Non-hodgkin Lymphoma to compare the difference in efficacy.
Eligibility
Inclusion Criteria:
- DLBCL Lymphoma subtype --No comorbid disease
Exclusion Criteria:
- Pregnancy
- Peptic ulcer
- Severe cardiac disease
- Osteoporosis